Literature DB >> 33541779

Dissecting the role of Amerindian genetic ancestry and the ApoE ε4 allele on Alzheimer disease in an admixed Peruvian population.

Maria Victoria Marca-Ysabel1, Farid Rajabli2, Mario Cornejo-Olivas3, Patrice G Whitehead2, Natalia K Hofmann2, Maryenela Zaida Illanes Manrique1, Diego Martin Veliz Otani4, Ana Karina Milla Neyra1, Sheila Castro Suarez5, Maria Meza Vega6, Larry D Adams2, Pedro R Mena2, Isasi Rosario7, Michael L Cuccaro7, Jeffery M Vance7, Gary W Beecham7, Nilton Custodio8, Rosa Montesinos8, Pilar E Mazzetti Soler9, Margaret A Pericak-Vance10.   

Abstract

Alzheimer disease (AD) is the leading cause of dementia in the elderly and occurs in all ethnic and racial groups. The apolipoprotein E (ApoE) ε4 is the most significant genetic risk factor for late-onset AD and shows the strongest effect among East Asian populations followed by non-Hispanic white populations and has a relatively lower effect in African descent populations. Admixture analysis in the African American and Puerto Rican populations showed that the variation in ε4 risk is correlated with the genetic ancestral background local to the ApoE gene. Native American populations are substantially underrepresented in AD genetic studies. The Peruvian population with up to ~80 of Amerindian (AI) ancestry provides a unique opportunity to assess the role of AI ancestry in AD. In this study, we assess the effect of the ApoE ε4 allele on AD in the Peruvian population. A total of 79 AD cases and 128 unrelated cognitive healthy controls from Peruvian population were included in the study. Genome-wide genotyping was performed using the Illumina Global screening array v2.0. Global ancestry and local ancestry analyses were assessed. The effect of the ApoE ε4 allele on AD was tested using a logistic regression model by adjusting for age, gender, and population substructure (first 3 principal components). Results showed that the genetic ancestry surrounding the ApoE gene is predominantly AI (60.6%) and the ε4 allele is significantly associated with increased risk of AD in the Peruvian population (odds ratio = 5.02, confidence interval: 2.3-12.5, p-value = 2e-4). Our results showed that the risk for AD from ApoE ε4 in Peruvians is higher than we have observed in non-Hispanic white populations. Given the high admixture of AI ancestry in the Peruvian population, it suggests that the AI genetic ancestry local to the ApoE gene is contributing to a strong risk for AD in ε4 carriers. Our data also support the findings of an interaction between the genetic risk allele ApoE ε4 and the ancestral backgrounds located around the genomic region of ApoE gene.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease (AD); Amerindian (AI) genetic ancestry; Apolipoprotein E (ApoE)

Mesh:

Substances:

Year:  2020        PMID: 33541779      PMCID: PMC8122013          DOI: 10.1016/j.neurobiolaging.2020.10.003

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  41 in total

1.  Robust relationship inference in genome-wide association studies.

Authors:  Ani Manichaikul; Josyf C Mychaleckyj; Stephen S Rich; Kathy Daly; Michèle Sale; Wei-Min Chen
Journal:  Bioinformatics       Date:  2010-10-05       Impact factor: 6.937

2.  RFMix: a discriminative modeling approach for rapid and robust local-ancestry inference.

Authors:  Brian K Maples; Simon Gravel; Eimear E Kenny; Carlos D Bustamante
Journal:  Am J Hum Genet       Date:  2013-08-01       Impact factor: 11.025

3.  Genetic factors for the development of Alzheimer disease in the Cherokee Indian.

Authors:  R N Rosenberg; R W Richter; R C Risser; K Taubman; I Prado-Farmer; E Ebalo; J Posey; D Kingfisher; D Dean; M F Weiner; D Svetlik; P Adams; L S Honig; C M Cullum; F V Schaefer; G D Schellenberg
Journal:  Arch Neurol       Date:  1996-10

4.  APOE ε4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba.

Authors:  Hugh C Hendrie; Jill Murrell; Olusegun Baiyewu; Kathleen A Lane; Christianna Purnell; Adesola Ogunniyi; Frederick W Unverzagt; Kathleen Hall; Christopher M Callahan; Andrew J Saykin; Oye Gureje; Ann Hake; Tatiana Foroud; Sujuan Gao
Journal:  Int Psychogeriatr       Date:  2014-02-24       Impact factor: 3.878

5.  Apolipoprotein E4 and tau allele frequencies among Choctaw Indians.

Authors:  J Neil Henderson; Richard Crook; Julia Crook; John Hardy; Luisa Onstead; Linda Carson-Henderson; Pat Mayer; Bea Parker; Ronald Petersen; Birdie Williams
Journal:  Neurosci Lett       Date:  2002-05-10       Impact factor: 3.046

6.  Apolipoprotein E-associated risk for Alzheimer's disease in the African-American population is genotype dependent.

Authors:  A Sahota; M Yang; S Gao; S L Hui; O Baiyewu; O Gureje; S Oluwole; A Ogunniyi; K S Hall; H C Hendrie
Journal:  Ann Neurol       Date:  1997-10       Impact factor: 10.422

7.  The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics.

Authors:  M X Tang; Y Stern; K Marder; K Bell; B Gurland; R Lantigua; H Andrews; L Feng; B Tycko; R Mayeux
Journal:  JAMA       Date:  1998-03-11       Impact factor: 56.272

8.  Role of genes and environments for explaining Alzheimer disease.

Authors:  Margaret Gatz; Chandra A Reynolds; Laura Fratiglioni; Boo Johansson; James A Mortimer; Stig Berg; Amy Fiske; Nancy L Pedersen
Journal:  Arch Gen Psychiatry       Date:  2006-02

9.  Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta-analysis.

Authors:  Mengying Liu; Chen Bian; Jiqiang Zhang; Feng Wen
Journal:  Sci Rep       Date:  2014-03-17       Impact factor: 4.379

10.  Evolutionary genomic dynamics of Peruvians before, during, and after the Inca Empire.

Authors:  Daniel N Harris; Wei Song; Amol C Shetty; Kelly S Levano; Omar Cáceres; Carlos Padilla; Víctor Borda; David Tarazona; Omar Trujillo; Cesar Sanchez; Michael D Kessler; Marco Galarza; Silvia Capristano; Harrison Montejo; Pedro O Flores-Villanueva; Eduardo Tarazona-Santos; Timothy D O'Connor; Heinner Guio
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-26       Impact factor: 11.205

View more
  2 in total

Review 1.  Factors Influencing Alzheimer's Disease Risk: Whether and How They are Related to the APOE Genotype.

Authors:  Rong Zhang; Xiaojiao Xu; Hang Yu; Xiaolan Xu; Manli Wang; Weidong Le
Journal:  Neurosci Bull       Date:  2022-02-11       Impact factor: 5.271

2.  APOE alleles' association with cognitive function differs across Hispanic/Latino groups and genetic ancestry in the study of Latinos-investigation of neurocognitive aging (HCHS/SOL).

Authors:  Einat Granot-Hershkovitz; Wassim Tarraf; Nuzulul Kurniansyah; Martha Daviglus; Carmen R Isasi; Robert Kaplan; Melissa Lamar; Krista M Perreira; Sylvia Wassertheil-Smoller; Ariana Stickel; Bharat Thyagarajan; Donglin Zeng; Myriam Fornage; Charles S DeCarli; Hector M González; Tamar Sofer
Journal:  Alzheimers Dement       Date:  2020-11-06       Impact factor: 21.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.